Study Overview
This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.
Description
Prospective, multi-center, cluster-randomized trial of a hospital Infection Preventionist (IP)-led quality improvement study to provide clinical teams with just-in-time clinical education and reinforcement of existing best practices recommendations based on the output of a possible Central Line Associated Blood Stream Infection (CLABSI) Machine Learning (ML) prediction model.
The objective is to determine whether providing this model to Infection Preventionists will decrease the CLABSI rates versus routine clinical practice.
Official Title
Prediction and Reduction of Central Line Associated Blood Stream Infections: A Machine Learning Improvement Study
Quick Facts
Study Start:2025-07-01
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
| Inclusion Criteria | Exclusion Criteria |
|---|
| |
Contacts and Locations
Study Locations (Sites)
Providence Alaska Medical Center
Anchorage, Alaska, 99508
United States
St. Mary Medical Center
Apple Valley, California, 92307
United States
Providence Saint Joseph Medical Center
Burbank, California, 91505
United States
St. Jude Medical Center
Fullerton, California, 92835
United States
Providence Holy Cross Medical Center
Mission Hills, California, 91345
United States
Mission Hospital
Mission Viejo, California, 92691
United States
Queen of the Valley Medical Center
Napa, California, 94558
United States
St. Joseph Hospital
Orange, California, 92868
United States
Santa Rosa Memorial Hospital
Santa Rosa, California, 95405
United States
Providence Cedars-Sinai Tarzana Medical Center
Tarzana, California, 91356
United States
Providence St. Vincent Medical Center
Portland, Oregon, 97225
United States
Covenant Medical Center
Lubbock, Texas, 79416
United States
Swedish Medical Center Edmonds
Edmonds, Washington, 98026
United States
Providence Regional Medical Center Everett
Everett, Washington, 98201
United States
Providence St. Peter Hospital
Olympia, Washington, 98506
United States
Kadlec Regional Medical Center
Richland, Washington, 99352
United States
Swedish Medical Center Cherry Hill
Seattle, Washington, 98122
United States
Swedish Medical Center First Hill
Seattle, Washington, 98122
United States
Providence Sacred Heart Medical Center
Spokane, Washington, 99204
United States
Collaborators and Investigators
Sponsor: Swedish Medical Center
Study Record Dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
Study Start Date2025-07-01
Study Completion Date2027-12
Study Record Updates
Study Start Date2025-07-01
Study Completion Date2027-12
Terms related to this study
Keywords Provided by Researchers
- Inpatient
- CLABSI
- Central Line Associates Blood Stream Infections
- Infection Prevention
- artificial intelligence
- machine learning
- hai
- healthcare associated infection
Additional Relevant MeSH Terms
- Central Line Associated Blood Stream Infections (CLABSI)